Chiasma
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.
Show more...
CEO
Raj Kannan
Employees
84
Country
United States
ISIN
US16706W1027
Listings
0 Comments
Share your thoughts
FAQ
What is Chiasma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Chiasma stocks are traded under the ticker CXS.MU.
How many employees does Chiasma have?▼
As of August 19, 2026, the company has 84 employees.
In which sector is Chiasma located?▼
Chiasma operates in the Manufacturing sector.
When did Chiasma complete a stock split?▼
Chiasma has not had any recent stock splits.
Where is Chiasma headquartered?▼
Chiasma is headquartered in Needham, United States.